Developer docs
API playgroundTry for free, no card

Search company profiles

Medimo Oy

Full company profile

uuid004vfsd

Namestring
Medimo Oy
Legal namestring
Medimo Oy
Websiteurl
medimo.fi
Company typeenum
Private
Founded yearstring
-
Descriptiontext

Medimo Oy is a privately held Finnish consulting firm headquartered in Tampere, founded by Anu Gummerus, that delivers specialized pharmacovigilance, quality management, regulatory affairs, auditing, and marketing material review services to pharmaceutical and medical device companies across the Nordic countries and broader Europe. The company operates with a remote team of seven named personnel distributed across four Finnish locations, providing services that span the full lifecycle of medicinal products — including EU QPPV responsibilities, QP batch release, marketing authorisation applications and maintenance, GVP/GMP/GDP auditing, promotional material review, and embedded consultant outsourcing. Pricing is structured on either monthly retainer or hourly billing bases per individual consulting contract, with multi-year engagements typical for ongoing QPPV and outsourcing functions.

The underlying technology stack is essentially human expertise: there is no proprietary software platform, AI tooling, or productized technology. Medimo's competitive positioning relies on the deep regulatory credentials of its personnel — including a former EU QPPV with 20+ years' experience, a Qualified Person with ATMP and sterile product expertise, a former European Medicines Agency contributor, and a pharmacist-toxicologist — together with documented specialization in Nordic local regulatory requirements that few competitors can match. Distribution occurs entirely through direct B2B sales, complemented by content marketing (bilingual blog, LinkedIn), industry event participation, and referrals via the EuDRAcon pan-European consultancy network.

The business model is classic professional services consulting: revenue derives from billable consultant hours and retainer contracts, acquired through founder-led outreach, networking, and inbound contacts via the website and meeting booking. The company has no external investors, no parent entity, and no disclosed funding history. Medimo's customer base is split between pharmaceutical companies (primary) and medical device companies (primary), with use cases including EU QPPV outsourcing, batch release by QPs, literature monitoring across Nordic countries, deviation/CAPA process support, and audit preparation — all targeting compliance with GVP, GMP, GDP, and EU marketing authorisation regulations.

Short descriptiontext

Medimo Oy is a privately held Finnish consulting firm providing pharmacovigilance, quality management, regulatory affairs, auditing, and marketing material review services to pharmaceutical and medical device companies across the Nordic countries and Europe.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersTampere, Finland
HQ citystring
Tampere
HQ countrystring
Finland
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pharmacovigilance consulting, regulatory affairs services, quality management consulting, GMP GDP auditing, marketing authorization services
Industry2 codes
PRIMARYHLAGAKAI
Clinical Quality Assurance (GCP QA, TMF/QMS oversight)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Regulatory Affairs, Quality & Compliance Services (GxP)
SECONDARYHLAGAOAC
Medical Writing & Clinical Documentation FSP
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Scientific Staffing & Functional Service Providers (FSP)
NAICS code1 code
  • Scientific Research and Development Services5417
SIC code1 code
  • Services-Health Services8000
Product category
Pharmaceutical Regulatory Consulting
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Regulatory Affairs & Pharmacovigilance Consulting
TypeProfessional Services
Description

Medimo provides consulting services across the full lifecycle of medicinal products, including pharmacovigilance, quality management, regulatory affairs, auditing, marketing material review, and outsourcing. Revenue is generated through professional consulting engagements, with pricing based on either monthly fees or hourly billing as noted in consulting contract discussions.

medimo.fi
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Marketing or Sales, Technology or R&D
Pricing details1 tier
1Monthly fee or hourly billing consulting arrangements
ModelOtherBilling cadenceMulti-year contract
Notes

Pricing structures include monthly fee arrangements or hourly billing, with scope defined in individual consulting contracts. Exact figures are not publicly disclosed.

medimo.fi
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Medimo Oy is a Finnish pharmaceutical consulting firm providing pharmacovigilance, quality management, regulatory affairs, auditing, marketing material review, and outsourcing services to pharmaceutical and medical device companies. Its services cover the entire medicinal product lifecycle, including EU QPPV responsibilities, drug batch release by Qualified Persons, GVP/GMP/GDP compliance auditing, marketing authorisation applications, and embedded consulting. The company specialises in Nordic local regulatory requirements and operates across Europe through the EuDRAcon network.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Medimo Oy is a consulting and solution provider offering integrated pharmacovigilance, quality, and regulatory affairs services for the pharmaceutical industry. The company's portfolio consists of six interconnected service areas: Pharmacovigilance (covering GVP-compliant adverse event management, EU QPPV functions, and local Nordic pharmacovigilance contacts), Quality Services (encompassing GDP/GMP quality assurance and quality management system consulting), Auditing (GVP system audits and GMP/GDP compliance audits), Review of Promotional Material (ethical, medical, and linguistic review of marketing materials), Regulatory Affairs/Marketing Authorisations (marketing authorisation applications, maintenance, SmPC writing, and translations), and Outsourcing (placing expert consultants within client organisations). These services are designed to cover the entire lifecycle of medicinal products and medical devices, from development through market launch to post-authorisation maintenance, with particular expertise in Nordic country requirements.

Product and service6 records
1Pharmacovigilance (Lääketurvatoiminta)
CategoryPharmacovigilance consulting
Description

Good Vigilance Practice (GVP) compliant pharmacovigilance services covering the entire medicine lifecycle, including adverse event reporting, signal detection, PSMF management, EU QPPV responsibilities, and local pharmacovigilance contact services for human and veterinary medicinal products. Designed for pharmaceutical companies requiring outsourced pharmacovigilance functions.

2Quality Services (Laatupalvelut)
CategoryQuality management consulting
Description

Quality management and quality process consulting services including GDP (Good Distribution Practice) and GMP (Good Manufacturing Practice) quality assurance, deviation management, CAPA systems, and quality management system development and maintenance. Designed for pharmaceutical companies requiring quality compliance support.

3Auditing
CategoryCompliance auditing
Description

Comprehensive auditing services for pharmacovigilance systems (GVP audits), GMP-compliant audits of manufacturing plants, active substance plants, packaging material manufacturers, contract laboratories, and GDP-compliant distribution audits. Designed for pharmaceutical companies requiring compliance verification.

4Review of Promotional Material (Markkinoinnin valvonta)
CategoryMarketing material compliance review
Description

Review of promotional, marketing, and educational materials for medicinal products and medical devices, including ethical and medical reviews of marketing materials for prescription and OTC drugs, linguistic review, and compliance verification. Designed for pharmaceutical and medical device companies.

5Regulatory Affairs / Marketing Authorisations (Myyntiluvat)
CategoryRegulatory affairs consulting
Description

Complete marketing authorisation services for human and veterinary drugs including application preparation, MA maintenance, variations, renewals, SmPC and product information text writing, translations, and regulatory database updates. Designed for pharmaceutical companies requiring regulatory affairs support.

6Outsourcing (Ulkoistaminen)
CategoryConsulting outsourcing
Description

Staff outsourcing services providing expert consultants embedded within client companies for regulatory affairs, pharmacovigilance, and quality tasks, offering interactive collaboration and on-site support. Designed for pharmaceutical companies needing embedded regulatory expertise.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
1EuDRAcon
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-06-09
Description

EuDRAcon is a pan-European network of independent regulatory affairs consultancy companies dealing with medicinal products, medical devices, cosmetics, and food supplements. Medimo is a member, acting as a local consultancy partner in Finland. Through the network, Medimo provides access to regulatory expertise across 28 EU member states and can respond to queries about Finnish local regulations concerning regulatory affairs, pharmacovigilance, and quality.

medimo.fi
Recent move3 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Global CRO and life sciences services giant offering regulatory, PV and quality services alongside broader clinical and commercial offerings. Represents the scaled incumbent Medimo competes against.

2Navitas Life Sciences
TypeDirect peer
Description

Regulatory, pharmacovigilance and clinical services consultancy serving pharma and biotech clients. Closely comparable service offerings and client profile to Medimo.

TypeDirect peer
Description

Regulatory compliance, pharmacovigilance and quality consulting firm serving pharma, biotech and medical device companies globally. Direct overlap with Medimo's core service lines.

TypeBroad incumbent
Description

Global CRO offering regulatory, pharmacovigilance and quality services among a broad portfolio. Established incumbent competing for the same enterprise clients Medimo targets.

TypeDirect peer
Description

Specialised regulatory affairs, pharmacovigilance and quality consulting firm serving pharma and medical device clients across Europe. Highly comparable service mix to Medimo, operating at much larger scale.

TypeBroad incumbent
Description

Major global CRO with regulatory affairs, pharmacovigilance and quality consulting capabilities. Provides the wider market context and competitive benchmark for Medimo.

TypeDirect peer
Description

European pharmacovigilance, regulatory and quality consultancy focused on pharma and medical devices. Directly comparable GxP service portfolio and target client base to Medimo.

8Diamond Pharma Services
TypeDirect peer
Description

Pharmacovigilance, regulatory affairs and quality assurance consultancy supporting pharma clients. Direct competitor in the same niche consulting segment as Medimo.

TypeBroad incumbent
Description

Large CRO with regulatory and pharmacovigilance service lines serving pharma clients globally. Broad incumbent in the same regulatory/quality consulting space.

TypeDirect peer
Description

Pharmaceutical regulatory affairs and pharmacovigilance consultancy with European footprint. Direct peer in the regulatory/PV specialist space.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles7 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Medimo Oy

Pharmaceutical Regulatory Consultingmedimo.fi

Medimo Oy is a privately held Finnish consulting firm providing pharmacovigilance, quality management, regulatory affairs, auditing, and marketing material review services to pharmaceutical and medical device companies across the Nordic countries and Europe.

What Medimo Oy does

Medimo Oy is a privately held Finnish consulting firm headquartered in Tampere, founded by Anu Gummerus, that delivers specialized pharmacovigilance, quality management, regulatory affairs, auditing, and marketing material review services to pharmaceutical and medical device companies across the Nordic countries and broader Europe. The company operates with a remote team of seven named personnel distributed across four Finnish locations, providing services that span the full lifecycle of medicinal products — including EU QPPV responsibilities, QP batch release, marketing authorisation applications and maintenance, GVP/GMP/GDP auditing, promotional material review, and embedded consultant outsourcing. Pricing is structured on either monthly retainer or hourly billing bases per individual consulting contract, with multi-year engagements typical for ongoing QPPV and outsourcing functions.

The underlying technology stack is essentially human expertise: there is no proprietary software platform, AI tooling, or productized technology. Medimo's competitive positioning relies on the deep regulatory credentials of its personnel — including a former EU QPPV with 20+ years' experience, a Qualified Person with ATMP and sterile product expertise, a former European Medicines Agency contributor, and a pharmacist-toxicologist — together with documented specialization in Nordic local regulatory requirements that few competitors can match. Distribution occurs entirely through direct B2B sales, complemented by content marketing (bilingual blog, LinkedIn), industry event participation, and referrals via the EuDRAcon pan-European consultancy network.

The business model is classic professional services consulting: revenue derives from billable consultant hours and retainer contracts, acquired through founder-led outreach, networking, and inbound contacts via the website and meeting booking. The company has no external investors, no parent entity, and no disclosed funding history. Medimo's customer base is split between pharmaceutical companies (primary) and medical device companies (primary), with use cases including EU QPPV outsourcing, batch release by QPs, literature monitoring across Nordic countries, deviation/CAPA process support, and audit preparation — all targeting compliance with GVP, GMP, GDP, and EU marketing authorisation regulations.

Medimo Oy firmographics

Firmographics
Name
Medimo Oy
Legal name
Medimo Oy
Website
https://medimo.fi
Company type
Private
Operating status
Operating
Headcount range
1–10 employees
Short description
Medimo Oy is a privately held Finnish consulting firm providing pharmacovigilance, quality management, regulatory affairs, auditing, and marketing material review services to pharmaceutical and medical device companies across the Nordic countries and Europe.
Ownership category
akta.pro rank

Medimo Oy industry classification

Industry
Product category
Pharmaceutical Regulatory Consulting
NAICS
Scientific Research and Development Services (5417)
SIC
Services-Health Services (8000)
akta.pro industry
PRIMARYHLAGAKAI
Clinical Quality Assurance (GCP QA, TMF/QMS oversight)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Regulatory Affairs, Quality & Compliance Services (GxP)
SECONDARYHLAGAOAC
Medical Writing & Clinical Documentation FSP
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Scientific Staffing & Functional Service Providers (FSP)

Keywords

  • Pharmacovigilance consulting
  • Regulatory affairs services
  • Quality management consulting
  • GMP GDP auditing
  • Marketing authorization services

Where Medimo Oy is headquartered

Location

Headquarters

HQ city
Tampere
HQ country
Finland
HQ region
Europe

Offices1 record

Markets served

Medimo Oy business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D

Revenue model

  1. Regulatory Affairs & Pharmacovigilance Consulting: Medimo provides consulting services across the full lifecycle of medicinal products, including pharmacovigilance, quality management, regulatory affairs, auditing, marketing material review, and outsourcing. Revenue is generated through professional consulting engagements, with pricing based on either monthly fees or hourly billing as noted in consulting contract discussions.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractMonthly fee or hourly billing consulting arrangements

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Medimo Oy product offering

Product offering

Core offering

Medimo Oy is a Finnish pharmaceutical consulting firm providing pharmacovigilance, quality management, regulatory affairs, auditing, marketing material review, and outsourcing services to pharmaceutical and medical device companies. Its services cover the entire medicinal product lifecycle, including EU QPPV responsibilities, drug batch release by Qualified Persons, GVP/GMP/GDP compliance auditing, marketing authorisation applications, and embedded consulting. The company specialises in Nordic local regulatory requirements and operates across Europe through the EuDRAcon network.

Product overview

Medimo Oy is a consulting and solution provider offering integrated pharmacovigilance, quality, and regulatory affairs services for the pharmaceutical industry. The company's portfolio consists of six interconnected service areas: Pharmacovigilance (covering GVP-compliant adverse event management, EU QPPV functions, and local Nordic pharmacovigilance contacts), Quality Services (encompassing GDP/GMP quality assurance and quality management system consulting), Auditing (GVP system audits and GMP/GDP compliance audits), Review of Promotional Material (ethical, medical, and linguistic review of marketing materials), Regulatory Affairs/Marketing Authorisations (marketing authorisation applications, maintenance, SmPC writing, and translations), and Outsourcing (placing expert consultants within client organisations). These services are designed to cover the entire lifecycle of medicinal products and medical devices, from development through market launch to post-authorisation maintenance, with particular expertise in Nordic country requirements.

Differentiator

Problem solved

Functional benefit

Products and services

  • Pharmacovigilance (Lääketurvatoiminta) Good Vigilance Practice (GVP) compliant pharmacovigilance services covering the entire medicine lifecycle, including adverse event reporting, signal detection, PSMF management, EU QPPV responsibilities, and local pharmacovigilance contact services for human and veterinary medicinal products. Designed for pharmaceutical companies requiring outsourced pharmacovigilance functions.
  • Quality Services (Laatupalvelut) Quality management and quality process consulting services including GDP (Good Distribution Practice) and GMP (Good Manufacturing Practice) quality assurance, deviation management, CAPA systems, and quality management system development and maintenance. Designed for pharmaceutical companies requiring quality compliance support.
  • Auditing Comprehensive auditing services for pharmacovigilance systems (GVP audits), GMP-compliant audits of manufacturing plants, active substance plants, packaging material manufacturers, contract laboratories, and GDP-compliant distribution audits. Designed for pharmaceutical companies requiring compliance verification.
  • Review of Promotional Material (Markkinoinnin valvonta) Review of promotional, marketing, and educational materials for medicinal products and medical devices, including ethical and medical reviews of marketing materials for prescription and OTC drugs, linguistic review, and compliance verification. Designed for pharmaceutical and medical device companies.
  • Regulatory Affairs / Marketing Authorisations (Myyntiluvat) Complete marketing authorisation services for human and veterinary drugs including application preparation, MA maintenance, variations, renewals, SmPC and product information text writing, translations, and regulatory database updates. Designed for pharmaceutical companies requiring regulatory affairs support.
  • Outsourcing (Ulkoistaminen) Staff outsourcing services providing expert consultants embedded within client companies for regulatory affairs, pharmacovigilance, and quality tasks, offering interactive collaboration and on-site support. Designed for pharmaceutical companies needing embedded regulatory expertise.

Companies that use Medimo Oy

Customer profile

Segments2 records

Ideal customer profiles2 records

Medimo Oy technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Medimo Oy partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • EuDRAconcoreStrategic or Co-development Partner · 9 June 2023EuDRAcon is a pan-European network of independent regulatory affairs consultancy companies dealing with medicinal products, medical devices, cosmetics, and food supplements. Medimo is a member, acting as a local consultancy partner in Finland. Through the network, Medimo provides access to regulatory expertise across 28 EU member states and can respond to queries about Finnish local regulations concerning regulatory affairs, pharmacovigilance, and quality.

Scale indicators3 records

Recent moves3 records

Expansion highlights6 records

Medimo Oy competitors and assessment

Company assessment

Broad incumbents

  • IQVIA: Global CRO and life sciences services giant offering regulatory, PV and quality services alongside broader clinical and commercial offerings. Represents the scaled incumbent Medimo competes against.
  • Labcorp Drug Development: Global CRO offering regulatory, pharmacovigilance and quality services among a broad portfolio. Established incumbent competing for the same enterprise clients Medimo targets.
  • Parexel: Major global CRO with regulatory affairs, pharmacovigilance and quality consulting capabilities. Provides the wider market context and competitive benchmark for Medimo.
  • ICON plc: Large CRO with regulatory and pharmacovigilance service lines serving pharma clients globally. Broad incumbent in the same regulatory/quality consulting space.

Direct peers

  • Navitas Life Sciences: Regulatory, pharmacovigilance and clinical services consultancy serving pharma and biotech clients. Closely comparable service offerings and client profile to Medimo.
  • ProPharma Group: Regulatory compliance, pharmacovigilance and quality consulting firm serving pharma, biotech and medical device companies globally. Direct overlap with Medimo's core service lines.
  • PharmaLex: Specialised regulatory affairs, pharmacovigilance and quality consulting firm serving pharma and medical device clients across Europe. Highly comparable service mix to Medimo, operating at much larger scale.
  • Arriello: European pharmacovigilance, regulatory and quality consultancy focused on pharma and medical devices. Directly comparable GxP service portfolio and target client base to Medimo.
  • Diamond Pharma Services: Pharmacovigilance, regulatory affairs and quality assurance consultancy supporting pharma clients. Direct competitor in the same niche consulting segment as Medimo.
  • Inpharmation: Pharmaceutical regulatory affairs and pharmacovigilance consultancy with European footprint. Direct peer in the regulatory/PV specialist space.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights6 records

Customer concentration

Medimo Oy social profiles

Digital presence

Medimo Oy financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Medimo Oy leadership team

Management profile

Number of profiles

Profiles7 records

Medimo Oy funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Medimo Oy M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Medimo Oy

What does Medimo Oy do?

Medimo Oy is a Finnish pharmaceutical consulting firm providing pharmacovigilance, quality management, regulatory affairs, auditing, marketing material review, and outsourcing services to pharmaceutical and medical device companies. Its services cover the entire medicinal product lifecycle, including EU QPPV responsibilities, drug batch release by Qualified Persons, GVP/GMP/GDP compliance auditing, marketing authorisation applications, and embedded consulting. The company specialises in Nordic local regulatory requirements and operates across Europe through the EuDRAcon network.

Is Medimo Oy a public or private company?

Medimo Oy is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Medimo Oy founded?

Medimo Oy was founded in -1. It employs 1 to 10 people.

Where is Medimo Oy based?

Medimo Oy is headquartered in Tampere, Finland, in the Europe region.

How does Medimo Oy make money?

One revenue line is on record: regulatory Affairs & Pharmacovigilance Consulting.

Who are Medimo Oy's main competitors?

Broad incumbents on record are IQVIA, Labcorp Drug Development, Parexel and ICON plc. Direct peers are Navitas Life Sciences, ProPharma Group, PharmaLex, Arriello, Diamond Pharma Services and Inpharmation.

Does Medimo Oy have an API?

No public API is recorded for Medimo Oy.

What industry is Medimo Oy in?

Medimo Oy's product category is Pharmaceutical Regulatory Consulting. Its primary akta.pro industry code is HLAGAKAI, Clinical Quality Assurance (GCP QA, TMF/QMS oversight), with a secondary code of HLAGAOAC, Medical Writing & Clinical Documentation FSP. Its NAICS code is 5417 and its SIC code is 8000.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales